- Home
- LFST vs INDV Comparison
LFST vs INDV Comparison
Compare LFST & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFST | INDV |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LFST | INDV |
|---|---|---|
| Price | $13.83 | $36.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $14.45 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 2.9M | 2.6M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 2.78 |
| Revenue | ★ $1,424,285,000.00 | $1,239,000,000.00 |
| Revenue This Year | $19.96 | $7.50 |
| Revenue Next Year | $14.48 | $5.07 |
| P/E Ratio | ★ N/A | $13.05 |
| Revenue Growth | ★ 13.85 | 4.29 |
| 52 Week Low | $5.87 | $27.68 |
| 52 Week High | $14.31 | $42.81 |
Technical Indicators
Market Signals| Indicator | LFST | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 72.29 | 57.90 |
| Support Level | $11.73 | $35.78 |
| Resistance Level | N/A | $41.83 |
| Average True Range (ATR) | 0.49 | 1.46 |
| MACD | 0.14 | 0.18 |
| Stochastic Oscillator | 96.20 | 84.29 |
Price Performance
Historical ComparisonAbout LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).